News

In October, the conference “Bionection – Partnering Conference for Technology Transfer in Life Sciences” was held in Dresden. One of the lectures was given by the CEO of BMC – Mr Andrzej Białkowski-Miler. The lecture regarded challenges and opportunities for the emerging innovative biotechnology markets on the example of Polish experiences. The conference was addressed… Read more »

At the Investment Forum in Tarnów, the invited experts in science, business and politics discussed current directions of development of the Polish and European economy. During the panel discussion “Biotechnology, telemedicine and computerisation – what will happen next?”, an important commentary was presented by Andrzej Białkowski – Miller. In his opinion, the medicine of the… Read more »

Selvita Investor’s Day was held on 26 April in Kraków. At On this occasion, the participants of this meeting, in addition to a laboratory tour, could listen to interesting lectures of the invited guests. One of them was the president of Biotech Management Consulting – Andrzej Białkowski-Miler. He presented a lecture on methods of valuation… Read more »

Puls Biznesu wrote about our report on the perspectives of global telemedicine market. Andrzej Białkowski – Miler (President of BMC) predicts that the telemedicine market will be developing dynamically. The roots of this development are complex and the market itself is multi-dimensional. One of its more interesting segments is the so-called mHealth which is based… Read more »

Report – “An upcoming boom. Global perspectives of development of the telemedicine market” We invite you to read the report “An upcoming boom. Global perspectives of development of the telemedicine market” written by us. This market is developing at an astronomical pace. It is estimated that it will be increasing by 15 percent per annum… Read more »

The Investment Forum held by “Parkiet” and “Rzeczpospolita” has come to an end. Many interesting topics were discussed during the debate. Invited panellists talked about changes in the retirement system and methods of securing one’s own financial future in the perspective of low retirement pensions. The discussion concerned also savings and investing. The President of… Read more »

Andrzej Białkowski-Miler presented the condition of the Polish biotechnological industry in an interview for Parkiet. Companies from this field are receiving increasing interest from the Stock Exchange Market. Many investors expect – not without a reason – return on capital analogical to the American market. In fact, long-term foundations of development of biotechnological companies are… Read more »

In July 2016 BMC supported OncoArendi Therapeutics in grant application for the project “Development of a first-in-class small molecule drug candidate for cancer treatment through YKL 40 inhibition” in the 1/1.1.1/2016 (“Fast track”) program by The National Centre for Research and Development. The project included substantive preparation of the grant application parts, concerning: – market… Read more »

In Autumn 2015 BMC supported Helix Polska in grant application for 1/1.1.1/2015 (“Fast track”) program by The National Centre for Research and Development, for the project “Development of a new, effective and highly specific therapy for breast cancer, with low toxicity profile, based on patented DOS47 technology platform, modifying tumor’s microenvironment and antitumor immune response… Read more »

In May and July 2015 BMC supported OncoArendi Therapeutics in grant applications for 1/1.1.1/2015 (“Fast track”) program by The National Centre for Research and Development. Commission included description of the market and the profitability of the project implementation in the application concerning “Preclinical research and clinical trials of a first-in-class development candidate in therapy of… Read more »